| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sacituzumab govitecan | far upstream element-binding protein 1 | biotech | NA | drugbank | Triple Negative Breast Neoplasms[MeSHID:D064726] Urothelium[MeSHID:D019459] Neoplasm Metastasis[MeSHID:D009362] Cessation of life[MeSHID:D003643] |
NA | approved,investigational | inhibitor |
| sacituzumab govitecan | tumor-associated calcium signal transducer 2 | biotech | NA | drugbank , DGIDB | Triple Negative Breast Neoplasms[MeSHID:D064726] Urothelium[MeSHID:D019459] Neoplasm Metastasis[MeSHID:D009362] Cessation of life[MeSHID:D003643] |
NA | approved,investigational | antibody |
| sacituzumab govitecan | dna topoisomerase 1 | biotech | NA | drugbank | Triple Negative Breast Neoplasms[MeSHID:D064726] Urothelium[MeSHID:D019459] Neoplasm Metastasis[MeSHID:D009362] Cessation of life[MeSHID:D003643] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||